Cathelicidin peptide LL-37: A multifunctional peptide involved in heart disease

This publication has 151 references indexed in Scilit:

• Self‐assembly of PEG–PPS polymers and LL‐37 peptide nanomicelles improves the oxidative microenvironment and promotes angiogenesis to facilitate chronic wound healing
  Bioengineering & Translational Medicine, 2023
• Cathelicidin (LL‐37) causes expression of inflammatory factors in coronary artery endothelial cells of Kawasaki disease by activating TLR4–NF‐κB–NLRP3 signaling
  Immunity, Inflammation and Disease, 2023
• Efficacy of LL-37 cream in enhancing healing of diabetic foot ulcer: a randomized double-blind controlled trial
  Archives of Dermatological Research, 2023
• Role of LL-37 in thrombotic complications in patients with COVID-19
  Cellular and Molecular Life Sciences, 2022
• Ginsenoside Rg1 attenuates cardiomyocyte apoptosis and inflammation via the TLR4/NF‐kB/NLRP3 pathway
  Journal of Cellular Biochemistry, 2019
• Neutrophil extracellular traps and fibrocytes in ST-segment elevation myocardial infarction
  Basic Research in Cardiology, 2019
• Exercise-induced circulating extracellular vesicles protect against cardiac ischemia–reperfusion injury
  Basic Research in Cardiology, 2017
• Myocardial Fibrosis: Biomedical Research from Bench to Bedside
  European Journal of Heart Failure, 2017
• Evidence that cathelicidin peptide LL‐37 may act as a functional ligand for CXCR2 on human neutrophils
  European Journal of Immunology, 2009
• Phylogeny, processing and expression of the rat Cathelicidin rCRAMP: a model for innate antimicrobial peptides
  Cellular and Molecular Life Sciences, 2003